The long noncoding RNA <i>lnc-HLX-2-7</i> is oncogenic in Group 3 medulloblastomasKeisuke Katsushima, Ranjan J. Perera, Eric H. Raabe et al.|Neuro-Oncology|2020Cited by 42
The therapeutic and diagnostic potential of regulatory noncoding RNAs in medulloblastomaPiyush Joshi, Ranjan J. Perera, Keisuke Katsushima et al.|Neuro-Oncology Advances|2019Cited by 23
The oncogenic circular RNA circ_63706 is a potential therapeutic target in sonic hedgehog-subtype childhood medulloblastomasKeisuke Katsushima, Ranjan J. Perera, Rudramani Pokhrel et al.|Acta Neuropathologica Communications|2023Cited by 15
Phase 1 study of mebendazole therapy for refractory/progressive or recurrent pediatric brain tumorsKenneth J. Cohen, Stacie Stapleton, Gregory J. Riggins et al.|Neuro-Oncology Practice|2025Cited by 3
CSIG-32. microRNA 211, A POTENTIAL THERAPEUTIC AGENT FOR GROUP 3 MEDULLOBLASTOMA IN CHILDRENKeisuke Katsushima, Ranjan J. Perera, Bongyong Lee et al.|Neuro-Oncology|2021Cited by 2